Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  3. CRON

(CRON)

NGM – Real Time Price. Currency in USD

2.50

-0.02 (-0.79%)

At close: Mar 27, 2026, 4:00 PM EDT

2.48

-0.03 (-1.00%)

After-hours: Mar 27, 2026, 7:32 PM EDT

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile
Top Canadian Marijuana Stocks To Watch This Month For Better Trading
27.03.2026

Top Canadian Marijuana Stocks To Watch This Month For Better Trading

The cannabis industry has made a tremendous impact on the world. From being once a taboo subject to now a well-respected and much more accepted industry. Even the thought of what may happen to a legal operator could shape the way marijuana stock investors think. At one point during the green rush, the fear of what could happen with no federal reform would shift how the market reacted. But as of 2026, those fears and worries have calmed down a lot.

Cannabis Operator CRON Rises 46% in a Year: Time to Buy, Sell or Hold?
26.03.2026

Cannabis Operator CRON Rises 46% in a Year: Time to Buy, Sell or Hold?

Shares of Cronos Group CRON have staged a strong recovery over the past year. The Canada-based cannabis operator's shares have risen 46% in the said time frame, significantly outperforming the industry, as shown in the chart below.

Cronos Group Inc. (CRON:CA) Presents at The 38th Annual Roth Conference Transcript
25.03.2026

Cronos Group Inc. (CRON:CA) Presents at The 38th Annual Roth Conference Transcript

Cronos Group Inc. (CRON:CA) Presents at The 38th Annual Roth Conference Transcript

Canadian Cannabis Stocks to Watch in March 2026 as Global Legalization Expands
10.03.2026

Canadian Cannabis Stocks to Watch in March 2026 as Global Legalization Expands

The global cannabis industry continues evolving as legalization slowly expands across multiple regions. Investors remain focused on companies positioned for long-term growth. Canadian cannabis producers still play a major role in this global expansion.

Cronos Group Inc. (CRON:CA) Q4 2025 Earnings Call Transcript
26.02.2026

Cronos Group Inc. (CRON:CA) Q4 2025 Earnings Call Transcript

Cronos Group Inc. (CRON:CA) Q4 2025 Earnings Call Transcript

Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
26.02.2026

Cronos Group Reports 2025 Fourth Quarter and Full-Year Results

Net revenue in Q4  2025 increased by 47% year-over-year to $44.5 million ; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million

Cronos: Geographic Expansion Backed By A Strong Balance Sheet
25.02.2026

Cronos: Geographic Expansion Backed By A Strong Balance Sheet

Cronos remains a Strong Buy, supported by robust fundamentals, international expansion, and a depressed $1B valuation with $784M in cash. CRON's acquisition of CanAdelaar and expansion into Europe and Australia position it for accelerated growth and margin improvement over the next 24-36 months. GrowCo's completed capacity expansion and 70% flower volume increase in 2026 are expected to drive top-line and EBITDA margin gains.

Videos

18.01.2026
Neutral
How to play cannabis stocks in 2026
19.12.2025
Positive
Trump signs executive order to reschedule cannabis. Here's what's next
19.12.2025
Negative
Trump sparks market shock with MAJOR marijuana move
19.12.2025
Negative
Former WH drug policy advisor: Mass commercialization and promotion of marijuana isn't a good thing